Bevatas 100mg Injection

About Bevatas 100mg Injection

Bevatas 100mg Injection contains Bevacizumab, a targeted anticancer medication used in combination with chemotherapy to treat various types of cancer, including metastatic breast cancer, colorectal cancer, lung cancer, kidney cancer, cervical cancer, brain cancer, and certain gynecological cancers such as ovarian, fallopian tube, and primary peritoneal cancer. It works by blocking the formation of new blood vessels that tumors need to grow and spread, helping to slow cancer progression. Women of childbearing age should use effective contraception during treatment and for at least six months after the last dose, as Bevacizumab may harm an unborn baby and can potentially affect fertility. Breastfeeding is not recommended during treatment due to possible risks to infant growth and development. Common side effects of Bevatas 100mg Injection include constipation, decreased appetite, runny nose, fever, skin-related reactions, and weight loss. Patients should inform their doctor about any history of high blood pressure, diabetes, heart disease, stomach disorders, or planned surgical procedures before starting treatment. Because this medicine may impair wound healing and increase the risk of bleeding, it is generally not recommended within 28 days before or after surgery. Patients should also report any dental problems requiring surgery, vision changes, severe headaches, or confusion, as these symptoms may indicate serious complications that require immediate medical attention. Regular monitoring by a healthcare professional helps ensure the safe and effective use of Bevatas 100mg Injection during cancer treatment.